-
Godzilla Minus Zero Review: Takashi Yamazaki’s Anti-Nuclear Allegory
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
DA Demands No-Work-No-Pay for Striking Municipal Workers in Coalition Talks
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
Malta Emerges as Premier Low-Season Destination for UK Travelers
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
UK Home Asking Prices Drop £6,745 in November Amid High Mortgage Rates
-
Mbeki Claims No Progress Since 2018; Author Cites Infrastructure and Economic Gains
-
Alex Georgiev Sets Personal Record to Win NCAA Pole Vault at Penn Relays
-
Qatar's Amir and Venezuelan Acting President Discuss Energy Cooperation
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
Emerging Growth Research Highlights Criticality of First Phosphate G7-Backed LFP Battery Onshoring Solution as Cleantech Sector Accelerates Post U.S. Midterms
-
Presidio Property Trust, Inc. Announces Earnings for the Quarter Ended September 30, 2026
-
Sekur Private Data Ltd. Provides Update on Expected Closing of Non-Brokered Private Placement
-
iFabric Corp Announces Record Revenues for Q3 2026 and the Nine Months Ended September 30, 2026
-
RenX Enterprises Reports Record Third Quarter Revenue of $4.49 Million, Up 27.6% Year Over Year
-
Aptevo Provides 3Q26 Business Update Highlighting Growing Momentum for Mipletamig and Reports Third Quarter Financial Results
-
Gladstone Capital Corporation Earnings Call and Webcast Information
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Wi2Wi Reports 35% Revenue Growth to US$2.36M and Returns to Profitability with US$268K Net Income in Q3 2026
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
Hawai‘i Falls to North Dakota State, Bowl Hopes Dashed
-
Big Mamma Founder Tigrane Seydoux Brings Italian Restaurant Group to Florida
-
Park Jin-young Denies Cult Allegations Against Firstfruits Group
RFK Jr vaccine panel targets childhood vaccinations in first meeting
A medical panel appointed by US Health Secretary Robert F. Kennedy Jr. held its first meeting Wednesday, pledging to revisit the childhood vaccine schedule and promoting themes long embraced by anti-vaccine activists.
The Advisory Committee on Immunization Practices (ACIP), an independent group that reviews scientific evidence to determine who should receive vaccines and when, rarely draws headlines.
But that changed after Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 sitting members earlier this month, accusing them of industry conflicts of interest.
He replaced them with eight new appointees, including scientist Robert Malone, known for promoting false claims during the Covid-19 pandemic.
The panel's new chair, Martin Kulldorff, co-authored the Great Barrington Declaration, which called for ending lockdowns in October 2020, even though it was known Covid vaccines were nearing approval.
Kulldorff opened the meeting by announcing a new working group to re-examine the childhood vaccine schedule. He raised questions about the potential cumulative effects of vaccine interactions and the wisdom of administering the Hepatitis B shot "on the day of birth."
Experts met the announcement with skepticism.
"The rationale for Hepatitis B vaccination prior to hospital discharge (not 'day of birth') for neonates is well documented and established -- but it's another pet cause of the anti-vaccine movement," Amesh Adalja, an infectious disease expert at Johns Hopkins University, told AFP.
The panel's first major test comes Thursday, when it votes on whether to recommend a newly approved antibody shot against RSV, or respiratory syncytial virus, for infants whose mothers did not receive an RSV vaccine during pregnancy.
- Fabricated citation -
The meeting agenda also signaled plans to revisit long-settled debates around thimerosal, a mercury-based preservative, and to highlight rare side effects linked to measles shots -- with no planned discussion of the overwhelming public health benefits of immunization.
Lyn Redwood, a nurse and former leader of Children's Health Defense -- the anti-vaccine group once chaired by Kennedy -- is scheduled to present Thursday on thimerosal.
Scientists reviewing her slides, posted ahead of the meeting, discovered she cited a 2008 paper by RF Berman titled "Low-level neonatal thimerosal exposure: Long-term consequences in the brain."
No such study exists. While Berman did publish a paper that year, it appeared in a different journal and found no link between thimerosal and autism.
The presentation was quietly revised without explanation. The incident echoed possible AI chatbot hallucinations blamed for similar sourcing errors in Kennedy's recent flagship Make America Healthy Again report.
The Centers for Disease Control and Prevention (CDC), which is overseeing the meeting, had been set to deliver a presentation defending thimerosal, but that document was deleted from the website at the last minute.
The panel will vote on thimerosal-containing flu vaccines on Thursday afternoon.
- Sweeping implications -
During a discussion on Covid-19 vaccines, Malone suggested that mRNA shots may have triggered novel, poorly understood effects on the immune system.
CDC scientist Sarah Meyer pushed back, saying the nation's vaccine safety systems would have flagged such issues if they had occurred.
The panel will also revive a debate on the combined measles, mumps, rubella, and varicella (MMRV) shot, which is offered as an alternative to separate MMR and varicella injections.
While the combined version spares children an extra jab, it slightly increases the risk of febrile seizures -- a rare and typically harmless side effect.
Current guidelines already recommend splitting the doses for a child's first shot at 12–47 months, leaving experts puzzled as to why the issue is being re-litigated.
As panelists scrutinize rare side effects, there is no plan to discuss the measles vaccine's enormous public health benefits -- including preventing millions of hospitalizations.
The United States, which declared measles eliminated in 2000, is experiencing its worst outbreak in decades -- with over 1,200 cases and three confirmed deaths this year.
ACIP's recommendations could carry sweeping implications, shaping school entry requirements and insurance coverage across the country.
A.Ruiz--AT